Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Liver Disease Treatment Market Report by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2025-2033
... 2025-2033. The growing elderly population worldwide, which is prone to several chronic illnesses, including liver disease, is stimulating the market. The liver is a vital organ of the human body that performs significant functions, such ... Read More
-
Aplastic Anemia - Global Clinical Trials Review, 2025
... line data relating to the clinical trials on Aplastic Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More
-
2025 Global: Hydroxychloroquine Sulfate Tablets Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
2025 Global: Immunoglobulins Market - Innovative Markets Forecast (2031) report
... based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research publisher ... Read More
-
In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033
... The growing prevalence of chronic diseases worldwide and the increasing R&D expenditure by pharmaceutical companies are propelling the market growth. In-vivo contract research organizations (CROs) are institutions that conduct extensive biopharmaceutical research on a contractual ... Read More
-
Veterinary Autoimmune Disease Therapeutics Global Market Report 2025
... disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Guillain-Barré Syndrome (GBS): ... Read More
-
Digital Biomarkers Market by Type of Product
... 18.48% during the forecast period, till 2035. The market opportunity for cell and gene therapy supply chain software has been distributed across the following segments: Type of Product Software / Applications Wearables Sensors Gaming Solutions ... Read More
-
Bispecific Antibodies Market by Therapeutic Area
... 9.5% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Therapeutic Area Autoimmune Disorders Genetic Disorders Hematological Malignancies Ophthalmic Disorders Skin Cancers Solid Tumors Mechanism ... Read More
-
In-vitro Diagnostics Enzymes Market Size, Share, and Outlook, 2025 Report- By Type (Proteases, Polymerase & Transcriptase, Ribonuclease, Others), By Disease , Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Others), By Technology (Histology Assays, Molecular Diagnostics, -PCR Assays, -NGS Assays, -Others), Clinical Chemistry), By End-user (Pharma & Biotech, Hospital & Diagnostic Labs, Contract Research Organizations (CROs), Academic Labs, 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on In-vitro Diagnostics Enzymes segments across 22 countries ... Read More
-
Global Celiac Diseases Drugs Market 2025-2029
... diseases drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Biopharmaceuticals Contract Manufacturing Market Size, Share, and Outlook, 2025 Report- By Source (Mammalian, Non-mammalian), By Service (Process Development, Fill & Finish Operations, Analytical & QC studies, Packaging), By Product (Biologics, BiosimilarsOthers), By Therapeutic Area (Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Biopharmaceuticals Contract Manufacturing segments across 22 countries ... Read More
-
Pharmaceutical Market Size, Share, and Outlook, 2025 Report- By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), 2021-2032
... potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Pharmaceutical segments across 22 countries from 2021 to 2032. Key segments in the ... Read More
-
Autoimmune Drugs Markets in China
... which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply ... Read More
-
Autoimmune Drugs Companies in China
... consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest ... Read More
-
Autoimmune Drugs Industry Forecasts - China Focus
... China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for ... Read More
-
US Apheresis Service Market Research Report Information by Service Type (Donor/Automated Apheresis, Therapeutic Apheresis, and Stem Cell Collection and Processing), by Application (Neurological Disorders, Autoimmune Disorders, Hematologic Disorders, Oncology, Metabolic Toxicology Disorders, Infectious Diseases, Cardiovascular Disorders, and Others), by End User (Hospitals, Blood Banks, Specialty Clinics, Research Laboratories, and Biotechnology Pharmaceutical Companies) Industry Forecast to 2035
... specific component (such as plasma, platelets, or white blood cells), and returning the remaining blood to the body. It is commonly employed for therapeutic objectives, including as removing excess components in particular disorders (for example, ... Read More
-
Eosinophilic Esophagitis Market, by Drug Class (Corticosteroids: Budesonide {Jorveza and Off-label budesonide} and Fluticasone; Proton Pump Inhibitor (PPI): Omeprazole, Esomeprazole, and Others; and Late Stage Pipeline Drugs: Dupixent, APT-1011, Lirentelimab (AK002), Cendakimab, Etrasimod, TAK-721, and Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... as a liquid. Oral steroids may be prescribed to treat people who have serious swallowing problems or weight loss. Proton pump inhibitors help with reflux symptoms and decrease inflammation. Market Dynamics Growing awareness regarding eosinophilic ... Read More
-
Antiphospholipid Syndrome Treatment Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Injectable Drug Delivery Devices Global Market Report 2025
... delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025
... molecule active pharmaceutical ingredient market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2025-2033
... 5.54% during 2025-2033. The increasing number of patients suffering from SLE, rising public awareness campaigns, and the easy availability of generic drugs represent some of the key factors driving the market. Systemic lupus erythematosus (SLE) ... Read More
-
Systemic Lupus Erythematosus Treatment Global Market Report 2025
... erythematosus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Companion Diagnostics Market Size, Share, By Offerings (Products and Services), Technology (Polymerase Chain Reaction (PCR), Next-generation Sequencing (NGS), Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and, Others), Therapeutic Area (Oncology, Immunology, Neurology, Autoimmune, Cardiovascular, Infectious Disease, and Others), End-User (Pharmaceutical & Biotechnological Companies, Contract Research Laboratories, Diagnostics Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035
... Disease, and Others), End-User (Pharmaceutical & Biotechnological Companies, Contract Research Laboratories, Diagnostics Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035 Companion diagnostics market is projected to grow from US$ 3.6 Billion ... Read More
-
PEGylated Drugs Market Research Report Information by Molecule (Macromolecular Drugs, Small Molecular Drugs and Lipid Nanoparticles (LNP) and Liposomes), by Application (Oncology, Neurology, Autoimmune Diseases, Haematology and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) Industry Forecast till 2035
... fragments, enzymes, and oligonucleotides, to covalent and non-covalent glycol polymer chains. It is a secure technique that is employed to enhance the therapeutic efficacy of medications in a clinical setting. Numerous pegylated pharmaceuticals have been ... Read More
Research Assistance
